Thus, he commented on the material of the Bloomberg agency, which, citing sources, reported that access was given to top managers of Russian companies, large businessmen and officials to an experimental vaccine developed by the Gamalei Research Center for Epidemiology and Microbiology.
As noted by Kuznetsov, clinical trials of two forms of vaccine are currently ongoing.
“After the completion of the tests, the issue of its state registration will be decided. At the moment, the vaccine has not been released into civilian circulation, its use outside the framework of clinical examinations is impossible, ”he told RIA Novosti.
Earlier, Sechenovskiy University spoke about the testing of a vaccine from COVID-19. It is noted that the second group of volunteers who participated in the trials of the vaccine against coronavirus infection COVID-19, developed by the National Research Center for Epidemiology and Microbiology named after N.F. Gamalei of the Ministry of Health of Russia, discharged from the clinic.
Director of the National Research Center for Epidemiology and Microbiology Alexander Gunzburg commented on the situation with the coronavirus vaccine in an interview with Nation News.